ArticleQuantitative imaging in medicine and surgery2026
Dual perfusion imaging with integrated positron emission tomography-magnetic resonance imaging for the detection of coronary microvascular dysfunction in patients with ischemia with no obstructive coronary artery disease: a study on myocardial perfusion imaging and T1 mapping.
Article in Quantitative imaging in medicine and surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Coronary microvascular dysfunction (CMVD) is a common cause of ischemia with no obstructive coronary arteries (INOCAs), a condition previously considered benign but now recognized to confer an increased risk of adverse cardiovascular events. The aim of this study was to compare the diagnostic performance of T1 mapping and myocardial perfusion reserve index (MPRI) in detecting CMVD in patients with INOCA, with positron emission tomography (PET) serving as the reference standard. Methods: Sixty-six patients with INOCA (mean age 55±9 years; 50% female) were prospectively enrolled from August 2024 to February 2026 and underwent an integrated 3.0-T PET-magnetic resonance imaging (MRI) examination. MRI-derived left ventricular function, native T1, postcontrast T1, extracellular volume (ECV), T2 mapping, and regadenoson stress/rest MPRI were obtained and compared between the CMVD group and the non-CMVD group. CMVD was defined as a PET-derived myocardial flow reserve (MFR) <2.0. Results: Patients with CMVD (n=28), as compared with patients without CMVD (n=38), exhibited higher native T1 (1,239±23 Conclusions: Native T1 and MPRI showed nonsignificant differences in their ability to detect CMVD, with consistent and complementary diagnostic value. As a contrast-free method, native T1 may serve as a potential initial screening option, particularly for patients with renal dysfunction.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.